25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Aroa Biosurgery Ltd
Buy, Hold or Sell?

Let's analyze Aroa together

I guess you are interested in Aroa Biosurgery Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Aroa Biosurgery Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Aroa Biosurgery Ltd

I send you an email if I find something interesting about Aroa Biosurgery Ltd.

1. Quick Overview

1.1. Quick analysis of Aroa (30 sec.)










1.2. What can you expect buying and holding a share of Aroa? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
A$0.25
Expected worth in 1 year
A$0.16
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
A$-0.10
Return On Investment
-17.4%

For what price can you sell your share?

Current Price per Share
A$0.56
Expected price per share
A$0.44 - A$0.565
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Aroa (5 min.)




Live pricePrice per Share (EOD)
A$0.56
Intrinsic Value Per Share
A$-0.71 - A$-0.51
Total Value Per Share
A$-0.45 - A$-0.26

2.2. Growth of Aroa (5 min.)




Is Aroa growing?

Current yearPrevious yearGrowGrow %
How rich?$58.7m$64.3m-$5.6m-9.6%

How much money is Aroa making?

Current yearPrevious yearGrowGrow %
Making money-$6.6m-$250.1k-$6.3m-96.2%
Net Profit Margin-15.4%-0.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Aroa (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Aroa?

Welcome investor! Aroa's management wants to use your money to grow the business. In return you get a share of Aroa.

First you should know what it really means to hold a share of Aroa. And how you can make/lose money.

Speculation

The Price per Share of Aroa is A$0.555. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aroa.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aroa, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.25. Based on the TTM, the Book Value Change Per Share is A$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aroa.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.02-3.5%-0.02-3.5%0.00-0.1%-0.02-3.1%-0.01-1.7%
Usd Book Value Change Per Share-0.02-2.9%-0.02-2.9%0.000.7%0.035.3%0.022.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.011.3%0.000.6%
Usd Total Gains Per Share-0.02-2.9%-0.02-2.9%0.000.7%0.046.6%0.023.4%
Usd Price Per Share0.37-0.37-0.71-0.48-0.43-
Price to Earnings Ratio-19.43--19.43--914.51--197.47--166.45-
Price-to-Total Gains Ratio-22.97--22.97-183.37-53.26--3.58-
Price to Book Ratio2.20-2.20-3.80-3.31-24.62-
Price-to-Total Gains Ratio-22.97--22.97-183.37-53.26--3.58-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.374514
Number of shares2670
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.020.03
Usd Total Gains Per Share-0.020.04
Gains per Quarter (2670 shares)-43.5397.90
Gains per Year (2670 shares)-174.13391.59
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-174-18476316382
20-348-358152631774
30-522-5322289471166
40-697-70630412621558
50-871-88038015781950
60-1045-105445618942342
70-1219-122853222092734
80-1393-140260825253126
90-1567-157668428413518
100-1741-175076031563910

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%2.010.012.08.3%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%5.05.00.050.0%13.011.00.054.2%
Dividend per Share0.00.01.00.0%1.00.02.033.3%2.00.03.040.0%2.00.08.020.0%2.00.022.08.3%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%6.04.00.060.0%14.010.00.058.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Aroa Biosurgery Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.024-0.0240%0.006-522%0.044-155%0.023-205%
Book Value Per Share--0.2520.2520%0.277-9%0.228+11%0.123+105%
Current Ratio--7.2567.2560%9.877-27%8.248-12%5.961+22%
Debt To Asset Ratio--0.1450.1450%0.126+16%0.177-18%0.264-45%
Debt To Equity Ratio--0.1700.1700%0.144+18%0.222-23%1.069-84%
Dividend Per Share----0%-0%0.011-100%0.005-100%
Eps---0.029-0.0290%-0.001-96%-0.025-11%-0.014-52%
Free Cash Flow Per Share---0.039-0.0390%-0.031-20%-0.024-39%-0.019-50%
Free Cash Flow To Equity Per Share---0.041-0.0410%-0.032-22%0.015-371%0.010-505%
Gross Profit Margin--6.7876.7870%121.477-94%27.212-75%14.106-52%
Intrinsic Value_10Y_max---0.509--------
Intrinsic Value_10Y_min---0.706--------
Intrinsic Value_1Y_max---0.030--------
Intrinsic Value_1Y_min---0.047--------
Intrinsic Value_3Y_max---0.105--------
Intrinsic Value_3Y_min---0.162--------
Intrinsic Value_5Y_max---0.201--------
Intrinsic Value_5Y_min---0.300--------
Market Cap191419500.0000%191419500.000191419500.0000%362145000.000-47%246948400.000-22%219049439.000-13%
Net Profit Margin---0.154-0.1540%-0.006-96%-0.294+91%-0.551+258%
Operating Margin---0.179-0.1790%-0.004-98%-0.257+43%-0.556+211%
Operating Ratio--1.1791.1790%1.137+4%1.288-8%1.591-26%
Pb Ratio2.1990%2.1992.1990%3.797-42%3.313-34%24.618-91%
Pe Ratio-19.4300%-19.430-19.4300%-914.508+4607%-197.472+916%-166.451+757%
Price Per Share0.5550%0.5550.5550%1.050-47%0.716-22%0.635-13%
Price To Free Cash Flow Ratio-14.3800%-14.380-14.3800%-33.987+136%-73.260+409%-45.726+218%
Price To Total Gains Ratio-22.9700%-22.970-22.9700%183.368-113%53.262-143%-3.577-84%
Quick Ratio--8.1798.1790%12.218-33%10.081-19%5.502+49%
Return On Assets---0.097-0.0970%-0.003-96%-0.097+0%-0.107+11%
Return On Equity---0.113-0.1130%-0.004-97%-0.124+9%-0.178+57%
Total Gains Per Share---0.024-0.0240%0.006-522%0.054-144%0.028-185%
Usd Book Value--58736938.28058736938.2800%64360241.697-9%52954517.427+11%28663979.154+105%
Usd Book Value Change Per Share---0.016-0.0160%0.004-522%0.030-155%0.016-205%
Usd Book Value Per Share--0.1700.1700%0.187-9%0.154+11%0.083+105%
Usd Dividend Per Share----0%-0%0.007-100%0.004-100%
Usd Eps---0.019-0.0190%-0.001-96%-0.017-11%-0.009-52%
Usd Free Cash Flow---8982382.914-8982382.9140%-7190160.439-20%-5524032.537-39%-3159652.644-65%
Usd Free Cash Flow Per Share---0.026-0.0260%-0.021-20%-0.016-39%-0.013-50%
Usd Free Cash Flow To Equity Per Share---0.028-0.0280%-0.022-22%0.010-371%0.007-505%
Usd Market Cap129169878.6000%129169878.600129169878.6000%244375446.000-47%166640780.320-22%147814561.437-13%
Usd Price Per Share0.3750%0.3750.3750%0.709-47%0.483-22%0.429-13%
Usd Profit---6647964.274-6647964.2740%-250136.477-96%-5575502.826-16%-3051905.382-54%
Usd Revenue--43201761.50943201761.5090%40021836.014+8%27605877.571+56%16022658.701+170%
Usd Total Gains Per Share---0.016-0.0160%0.004-522%0.037-144%0.019-185%
 EOD+0 -0MRQTTM+0 -0YOY+3 -315Y+13 -2310Y+15 -21

3.3 Fundamental Score

Let's check the fundamental score of Aroa Biosurgery Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-19.430
Price to Book Ratio (EOD)Between0-12.199
Net Profit Margin (MRQ)Greater than0-0.154
Operating Margin (MRQ)Greater than0-0.179
Quick Ratio (MRQ)Greater than18.179
Current Ratio (MRQ)Greater than17.256
Debt to Asset Ratio (MRQ)Less than10.145
Debt to Equity Ratio (MRQ)Less than10.170
Return on Equity (MRQ)Greater than0.15-0.113
Return on Assets (MRQ)Greater than0.05-0.097
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Aroa Biosurgery Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.269
Ma 20Greater thanMa 500.522
Ma 50Greater thanMa 1000.529
Ma 100Greater thanMa 2000.563
OpenGreater thanClose0.550
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Aroa Biosurgery Ltd

Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; Myriad Morcells Fine that delivers a bolus of biologically important ECM proteins to help kick start and sustain healing; and OviTex and OviTex PRS, a reinforced bioscaffolds for use in hernia repair and abdominal wall reconstruction, as well as breast reconstruction. The company also offers Symphony, a combination cellular and tissue product, indicated for the regeneration of functional tissue in complex wounds. Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand.

Fundamental data was last updated by Penke on 2024-09-19 19:51:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Aroa earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Aroa to the Medical Devices industry mean.
  • A Net Profit Margin of -15.4% means that $-0.15 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aroa Biosurgery Ltd:

  • The MRQ is -15.4%. The company is making a huge loss. -2
  • The TTM is -15.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-15.4%TTM-15.4%0.0%
TTM-15.4%YOY-0.6%-14.8%
TTM-15.4%5Y-29.4%+14.0%
5Y-29.4%10Y-55.1%+25.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.4%-11.7%-3.7%
TTM-15.4%-16.1%+0.7%
YOY-0.6%-16.3%+15.7%
5Y-29.4%-18.1%-11.3%
10Y-55.1%-24.1%-31.0%
4.3.1.2. Return on Assets

Shows how efficient Aroa is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aroa to the Medical Devices industry mean.
  • -9.7% Return on Assets means that Aroa generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aroa Biosurgery Ltd:

  • The MRQ is -9.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.7%TTM-9.7%0.0%
TTM-9.7%YOY-0.3%-9.3%
TTM-9.7%5Y-9.7%+0.0%
5Y-9.7%10Y-10.7%+1.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.7%-3.3%-6.4%
TTM-9.7%-3.7%-6.0%
YOY-0.3%-3.9%+3.6%
5Y-9.7%-3.3%-6.4%
10Y-10.7%-4.1%-6.6%
4.3.1.3. Return on Equity

Shows how efficient Aroa is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aroa to the Medical Devices industry mean.
  • -11.3% Return on Equity means Aroa generated $-0.11 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aroa Biosurgery Ltd:

  • The MRQ is -11.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -11.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.3%TTM-11.3%0.0%
TTM-11.3%YOY-0.4%-10.9%
TTM-11.3%5Y-12.4%+1.1%
5Y-12.4%10Y-17.8%+5.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.3%-3.7%-7.6%
TTM-11.3%-4.2%-7.1%
YOY-0.4%-4.2%+3.8%
5Y-12.4%-4.7%-7.7%
10Y-17.8%-6.0%-11.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Aroa Biosurgery Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Aroa is operating .

  • Measures how much profit Aroa makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aroa to the Medical Devices industry mean.
  • An Operating Margin of -17.9% means the company generated $-0.18  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aroa Biosurgery Ltd:

  • The MRQ is -17.9%. The company is operating very inefficient. -2
  • The TTM is -17.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-17.9%TTM-17.9%0.0%
TTM-17.9%YOY-0.4%-17.4%
TTM-17.9%5Y-25.7%+7.8%
5Y-25.7%10Y-55.6%+30.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.9%-20.8%+2.9%
TTM-17.9%-23.3%+5.4%
YOY-0.4%-14.3%+13.9%
5Y-25.7%-18.9%-6.8%
10Y-55.6%-23.2%-32.4%
4.3.2.2. Operating Ratio

Measures how efficient Aroa is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.18 means that the operating costs are $1.18 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Aroa Biosurgery Ltd:

  • The MRQ is 1.179. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.179. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.179TTM1.1790.000
TTM1.179YOY1.137+0.042
TTM1.1795Y1.288-0.109
5Y1.28810Y1.591-0.303
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1791.371-0.192
TTM1.1791.375-0.196
YOY1.1371.409-0.272
5Y1.2881.407-0.119
10Y1.5911.380+0.211
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Aroa Biosurgery Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Aroa is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 7.26 means the company has $7.26 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Aroa Biosurgery Ltd:

  • The MRQ is 7.256. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.256. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.256TTM7.2560.000
TTM7.256YOY9.877-2.621
TTM7.2565Y8.248-0.992
5Y8.24810Y5.961+2.287
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.2562.578+4.678
TTM7.2562.659+4.597
YOY9.8773.005+6.872
5Y8.2483.417+4.831
10Y5.9613.465+2.496
4.4.3.2. Quick Ratio

Measures if Aroa is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aroa to the Medical Devices industry mean.
  • A Quick Ratio of 8.18 means the company can pay off $8.18 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aroa Biosurgery Ltd:

  • The MRQ is 8.179. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.179. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.179TTM8.1790.000
TTM8.179YOY12.218-4.039
TTM8.1795Y10.081-1.902
5Y10.08110Y5.502+4.580
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ8.1791.543+6.636
TTM8.1791.589+6.590
YOY12.2181.842+10.376
5Y10.0812.330+7.751
10Y5.5022.558+2.944
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Aroa Biosurgery Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Aroa assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aroa to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.15 means that Aroa assets are financed with 14.5% credit (debt) and the remaining percentage (100% - 14.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aroa Biosurgery Ltd:

  • The MRQ is 0.145. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.145. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.145TTM0.1450.000
TTM0.145YOY0.126+0.020
TTM0.1455Y0.177-0.031
5Y0.17710Y0.264-0.087
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1450.400-0.255
TTM0.1450.403-0.258
YOY0.1260.358-0.232
5Y0.1770.442-0.265
10Y0.2640.463-0.199
4.5.4.2. Debt to Equity Ratio

Measures if Aroa is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aroa to the Medical Devices industry mean.
  • A Debt to Equity ratio of 17.0% means that company has $0.17 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aroa Biosurgery Ltd:

  • The MRQ is 0.170. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.170. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.170TTM0.1700.000
TTM0.170YOY0.144+0.026
TTM0.1705Y0.222-0.052
5Y0.22210Y1.069-0.847
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1700.567-0.397
TTM0.1700.563-0.393
YOY0.1440.530-0.386
5Y0.2220.636-0.414
10Y1.0690.694+0.375
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Aroa generates.

  • Above 15 is considered overpriced but always compare Aroa to the Medical Devices industry mean.
  • A PE ratio of -19.43 means the investor is paying $-19.43 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aroa Biosurgery Ltd:

  • The EOD is -19.430. Based on the earnings, the company is expensive. -2
  • The MRQ is -19.430. Based on the earnings, the company is expensive. -2
  • The TTM is -19.430. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.430MRQ-19.4300.000
MRQ-19.430TTM-19.4300.000
TTM-19.430YOY-914.508+895.078
TTM-19.4305Y-197.472+178.042
5Y-197.47210Y-166.451-31.021
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-19.430-1.039-18.391
MRQ-19.430-1.329-18.101
TTM-19.430-2.208-17.222
YOY-914.508-2.489-912.019
5Y-197.472-2.479-194.993
10Y-166.451-2.131-164.320
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aroa Biosurgery Ltd:

  • The EOD is -14.380. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -14.380. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -14.380. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.380MRQ-14.3800.000
MRQ-14.380TTM-14.3800.000
TTM-14.380YOY-33.987+19.607
TTM-14.3805Y-73.260+58.879
5Y-73.26010Y-45.726-27.534
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-14.380-1.513-12.867
MRQ-14.380-1.752-12.628
TTM-14.380-2.025-12.355
YOY-33.987-5.861-28.126
5Y-73.260-4.521-68.739
10Y-45.726-5.095-40.631
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Aroa is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 2.20 means the investor is paying $2.20 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Aroa Biosurgery Ltd:

  • The EOD is 2.199. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.199. Based on the equity, the company is underpriced. +1
  • The TTM is 2.199. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.199MRQ2.1990.000
MRQ2.199TTM2.1990.000
TTM2.199YOY3.797-1.598
TTM2.1995Y3.313-1.114
5Y3.31310Y24.618-21.305
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.1992.209-0.010
MRQ2.1992.093+0.106
TTM2.1992.333-0.134
YOY3.7972.937+0.860
5Y3.3134.108-0.795
10Y24.6184.603+20.015
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Aroa Biosurgery Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets101,822
Total Liabilities14,779
Total Stockholder Equity87,043
 As reported
Total Liabilities 14,779
Total Stockholder Equity+ 87,043
Total Assets = 101,822

Assets

Total Assets101,822
Total Current Assets63,294
Long-term Assets38,528
Total Current Assets
Cash And Cash Equivalents 10,564
Short-term Investments 17,148
Net Receivables 26,488
Inventory 7,430
Other Current Assets 1,665
Total Current Assets  (as reported)63,294
Total Current Assets  (calculated)63,294
+/- 0
Long-term Assets
Property Plant Equipment 20,369
Goodwill 5,077
Intangible Assets 12,993
Long-term Assets Other 85
Long-term Assets  (as reported)38,528
Long-term Assets  (calculated)38,525
+/- 3

Liabilities & Shareholders' Equity

Total Current Liabilities8,723
Long-term Liabilities6,056
Total Stockholder Equity87,043
Total Current Liabilities
Short-term Debt 921
Accounts payable 1,567
Other Current Liabilities 6,235
Total Current Liabilities  (as reported)8,723
Total Current Liabilities  (calculated)8,723
+/- 0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt5,900
Long-term Liabilities  (as reported)6,056
Long-term Liabilities  (calculated)5,900
+/- 156
Total Stockholder Equity
Common Stock134,591
Retained Earnings -56,984
Accumulated Other Comprehensive Income 9,436
Other Stockholders Equity 0
Total Stockholder Equity (as reported)87,043
Total Stockholder Equity (calculated)87,043
+/-0
Other
Capital Stock134,665
Cash and Short Term Investments 27,712
Common Stock Shares Outstanding 343,825
Current Deferred Revenue0
Liabilities and Stockholders Equity 101,822
Net Debt -3,747
Net Invested Capital 87,091
Net Working Capital 54,601
Property Plant and Equipment Gross 30,520
Short Long Term Debt Total 6,817



5.2. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-31
> Total Assets 
13,851
12,365
12,121
15,441
19,600
40,578
88,532
71,603
83,083
5,131
8,075
10,928
9,357
8,406
7,510
6,355
6,515
14,303
37,961
82,536
73,125
104,706
109,071
101,822
101,822109,071104,70673,12582,53637,96114,3036,5156,3557,5108,4069,35710,9288,0755,13183,08371,60388,53240,57819,60015,44112,12112,36513,851
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,816
1,761
833
922
8,894
12,627
55,253
44,753
74,244
73,140
63,294
63,29473,14074,24444,75355,25312,6278,8949228331,7612,8160000000000000
       Cash And Cash Equivalents 
10,000
224
383
338
1,700
13,432
9,514
12,229
2,076
3,284
4,037
5,851
3,772
2,205
1,506
680
800
3,647
4,279
41,478
32,480
5,730
8,930
10,564
10,5648,9305,73032,48041,4784,2793,6478006801,5062,2053,7725,8514,0373,2842,07612,2299,51413,4321,70033838322410,000
       Short-term Investments 
760
6,932
4,629
4,910
2,560
0
4,500
35
35
35
35
35
35
35
35
35
37
37
10
945
1,454
47,624
34,067
17,148
17,14834,06747,6241,4549451037373535353535353535354,50002,5604,9104,6296,932760
       Net Receivables 
11
49
89
184
112
95
7
88
20
63
34
38
310
461
61
4
9
2,484
5,248
7,328
6,599
15,958
13,413
26,488
26,48813,41315,9586,5997,3285,2482,48494614613103834632088795112184894911
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,681
2,570
3,905
3,312
3,700
4,522
7,430
7,4304,5223,7003,3123,9052,5701,68100000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,409
25,334
27,283
28,372
30,462
35,932
38,528
38,52835,93230,46228,37227,28325,3345,40900000000000000000
       Property Plant Equipment 
2,877
4,844
6,534
9,468
14,184
24,767
73,501
58,468
1,296
1,504
3,606
4,694
4,996
5,136
5,527
5,341
5,405
5,094
5,844
8,515
11,620
14,273
19,318
20,369
20,36919,31814,27311,6208,5155,8445,0945,4055,3415,5275,1364,9964,6943,6061,5041,29658,46873,50124,76714,1849,4686,5344,8442,877
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,317
5,317
5,364
5,084
5,147
5,184
5,077
5,0775,1845,1475,0845,3645,3175,31700000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
276
34
0
0
19,282
18,459
18,580
11,511
10,903
11,312
12,993
12,99311,31210,90311,51118,58018,45919,28200342760000000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-24,284
-5,317
188
157
138
118
85
85118138157188-5,317-24,28400000000000000000
> Total Liabilities 
12,043
2,203
2,350
2,584
4,373
8,019
58,226
89,720
105,731
3,454
3,319
1,588
355
827
586
444
235
12,535
26,440
19,677
19,434
11,304
13,695
14,779
14,77913,69511,30419,43419,67726,44012,5352354445868273551,5883,3193,454105,73189,72058,2268,0194,3732,5842,3502,20312,043
   > Total Current Liabilities 
12,025
2,203
1,304
1,719
3,156
2,851
11,733
50,132
99,205
209
1,772
1,489
201
628
331
375
175
2,252
7,829
6,128
14,038
6,238
7,405
8,723
8,7237,4056,23814,0386,1287,8292,2521753753316282011,4891,77220999,20550,13211,7332,8513,1561,7191,3042,20312,025
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124
658
1,030
9,656
547
523
921
9215235479,6561,03065812400000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
820
9,136
0
0
0
0009,1368200000000000000000000
       Accounts payable 
1,798
1,118
218
753
757
2,602
6,829
2,024
725
142
205
142
112
279
134
94
136
674
436
3,797
679
1,239
1,787
1,567
1,5671,7871,2396793,797436674136941342791121422051427252,0246,8292,6027577532181,1181,798
       Other Current Liabilities 
9,208
66
67
66
1,499
244
917
6,676
98,480
68
69
72
88
348
197
35
37
931
6,659
1,302
3,703
4,451
5,095
6,235
6,2355,0954,4513,7031,3026,65993137351973488872696898,4806,6769172441,4996667669,208
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,283
18,611
13,549
5,395
5,066
6,289
6,056
6,0566,2895,0665,39513,54918,61110,28300000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,391
431
2,989
5,716
5,287
6,548
0
06,5485,2875,7162,9894311,39100000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-124
-658
1,003
-3,889
4,914
6,129
5,900
5,9006,1294,914-3,8891,003-658-12400000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,332
0
01,3320000000000000000000000
> Total Stockholder Equity
841
9,410
9,029
12,259
14,505
32,218
31,461
0
0
1,677
4,756
9,340
9,002
7,579
6,925
5,912
6,280
1,768
11,521
62,859
53,691
93,402
95,377
87,043
87,04395,37793,40253,69162,85911,5211,7686,2805,9126,9257,5799,0029,3404,7561,6770031,46132,21814,50512,2599,0299,410841
   Retained Earnings -56,984-48,230-47,521-39,238-32,656-16,889-17,432-146,079-145,356-144,063-142,4470000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
470
674
1,218
3,591
5,450
6,481
9,436
9,4366,4815,4503,5911,21867447000000000000000000
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000



5.3. Balance Sheets

Currency in AUD. All numbers in thousands.




5.4. Cash Flows

Currency in AUD. All numbers in thousands.




5.5. Income Statements

Currency in AUD. All numbers in thousands.